Influence of morbidity and the use of health resources in patients who require care for generalised anxiety disorder in the primary health care setting;Influencia de la morbilidad y uso de recursos en pacientes que demandan atención por trastorno de ansiedad generalizada en el ámbito de la atención primaria de salud

Atencion Primaria

Volumn 40, Issue 12, 2008, Pages 603-610

  Sicras Mainar, Antoni ^a   Blanca Tamayo, Milagrosa ^b   Navarro Artieda, Ruth ^c   Pizarro Paixa, Israel ^d   Gómez Lus Centelles, Susana ^d  

^a Badalona Serveis Assistencials SA   (Spain)

^b SA Badalona Barcelona Espana   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d H LUNDBECK A S   (Denmark)

Author keywords

Generalised anxiety disorder; Health care costs; Primary care; Resources uses

Indexed keywords

ABSENTEEISM; ADULT; AGED; ANALYSIS OF COVARIANCE; ARTICLE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DEPRESSION; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; GENERALIZED ANXIETY DISORDER; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH CENTER; HEALTH ECONOMICS; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORBIDITY; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PRESCRIPTION; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; SMOKING; SPAIN; STATISTICAL ANALYSIS; TREATMENT INDICATION;

EID: 63349099621     PISSN: 02126567     EISSN: 15781275     Source Type: Journal    
DOI: 10.1016/S0212-6567(08)75693-2     Document Type: Article

References (40)

1. Ansseau M., Fischler B., Dierick M., Mignon A., and Leyman S. Prevalence and impact of generalized anxiety disorder and major depression in primary care in Belgium and Luxemburg: the GADIS study. Eur Psychiatry 20 (2005) 229-235
2. Kessler R.C., Chiu W.T., Demler O., and Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62 (2005) 617-627
3. Ruscio A.M., Chiu W.T., Roy-Byrne P., Stang P.E., Stein D.J., Wittchen H.U., et al. Broadening the definition of generalized anxiety disorder: effects on prevalence and associations with other disorders in the National Comorbidity Survey Replication. J Anxiety Disord 21 (2007) 662-676
4. Mergl R., Seidscheck I., Allgaier A.K., Möller H.J., Hegerl U., and Henkel V. Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition. Depress Anxiety 24 (2007) 185-195
5. Craske M.G., and Waters A.M. Panic disorder, phobias, and generalized anxiety disorder. Annu Rev Clin Psychol 1 (2005) 197-225
6. Roy-Byrne P.P., and Wagner A. Primary care perspectives on generalized anxiety disorder. J Clin Psychiatry 65 Suppl 13 (2004) 20-26
7. Kendler K.S., Walters E.E., Neale M.C., Kessler R.C., Heath A.C., and Eaves L.J. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism. Arch Gen Psychiatry 52 (1995) 374-383
8. Zhao X.H., Wang P.J., Li C.B., Wang J.H., Yang Z.Y., Hu Z.H., et al. Prefrontal and superior temporal lobe hyperactivity as a biological substrate of generalized anxiety disorders. Zhonghua Yi Xue Za Zhi 86 (2006) 955-960
9. Grant B.F., Hasin D.S., Stinson F.S., Dawson D.A., June Ruan W., Goldstein R.B., et al. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med 35 (2005) 1747-1759
10. Allen L.A., Gara M.A., Escobar J.I., Waitzkin H., and Silver R.C. Somatization: a debilitating syndrome in primary care. Psychosomatics 42 (2001) 63-67
11. Munk-Jorgensen P., Allgulander C., Dahl A.A., Foldager L., Holm M., Rasmussen I., et al. Prevalence of generalized anxiety disorder in general practice in Denmark, Finland, Norway, and Sweden. Psychiatr Serv 57 (2006) 1738-1744
12. Rodríguez B.F., Weisberg R.B., Pagano M.E., Bruce S.E., Spencer M.A., Culpepper L., et al. Characteristics and predictors of full and partial recovery from generalized anxiety disorder in primary care patients. J Nerv Ment Dis 194 (2006) 91-97
13. Kessler R.C., Berglund P.A., Dewit D.J., Ustün T.B., Wang P.S., and Wïttchen H.U. Distinguishing generalized anxiety disorder from major depression: prevalence and impairment from current pure and comorbid disorders in the US and Ontario. Int J Methods Psychiatr Res 11 (2002) 99-111
14. Kroenke K., Spitzer R.L., Williams J.B., Monahan P.O., and Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity and detection. Ann Intern Med 146 (2007) 317-325
15. Wittchen H.U., Hoyer J., Beesdo K., and Krause P. Problems and deficiencies in family physician's management of generalized anxiety disorders. Results of the GAD-P study and priorities for an improved care. Fortschr Med Orig 119 Suppl 1 (2001) 42-49
16. Goodwin R.D., Jacobi F., and Thefeld W. Mental disorders and asthma in the community. Arch Gen Psychiatry 60 (2003) 1125-1130
17. Honda K., and Goodwin R.D. Cancer and mental disorders in a national community sample: findings from the National Comorbidity Survey. Psychother Psychosom 73 (2004) 235-242
18. Henning E.R., Turk C.L., Mennin D.S., Fresco D.M., and Heimberg R.G. Impairment and quality of life in individuals with generalized anxiety disorder. Depress Anxiety 24 (2007) 342-349
19. Sareen J., Jacobi F., Cox B.J., Belik S.L., Clara I., and Stein M.B. Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. Arch Intern Med 166 (2006) 2109-2116
20. Boulenger J.P., and Capdevielle D. Pharmacological treatment of generalized anxiety disorders: rationale and limitations. Encephale 33 (2007) 84-94
21. Tyrer P., and Baldwin D. Generalised anxiety disorder. Lancet 368 (2006) 2156-2166
22. Barsky A.J., Orav E.J., and Bates D.W. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 62 (2005) 903-910
23. Wittchen H.U. Generalized anxiety disorder: prevalence, burden and cost to society. Depress Anxiety 16 (2002) 162-171
24. Andlin-Sobocki P., and Wittchen H.U. Cost of anxiety disorders in Europe. Eur J Neurol 12 Suppl 1 (2005) 39-44
25. a ed. (1994), American Psychiatric Association, Washington,DC
26. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID), Clinician Version: Administration Booklet (1996), American Psychiatric Press, Washington,DC
27. In: Lamberts H., Wood M., and Hofmans-Okkes I.M. (Eds). The International Classification of Primary Care in the European Community. With a multi-language layer (1993), Oxford University Press, Oxford
28. Charlson M.E., Pompei P., Ales K.L., and Mackenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
29. ® Case-mix System version 7.0-April, 2005. Baltimore: Johns Hopkins Bloomberg School of Public Health; 2005.
30. Weiner J.P., Starfield B.H., Steinwachs D.M., and Mumford L.M. Development and application of a population-oriented measure of ambulatory care case-mix. Med Care 29 (1991) 452-472
31. Guidelines for ATC classification. Oslo: Nordic Collaborating Centre for Drug Statistics Methodology; 1991.
32. Canadian Psychiatric Association. Clinical Practice Guidelines: Management of Anxiety Disorders. Can J Psychiatry 51 8 Suppl 2 (2006) 9S-91S Fe de errors: Can J Psychiatry. 2006; 51(10):623
33. GPT-1 Guía de Prescripción Terapéutica. Agencia Española de Medicamentos y Productos Sanitarios. Ministerio de Sanidad y Consumo (2006), Pharma Editores, Barcelona
34. García-Cardona F., Molins-Pérez G., Farré-Pradell J., Martín-Sánchez A., Pané-Mena O., and Gallego-Español R. Cost accountability in primary care: list of services. Aten Primaria 16 (1995) 141-145
35. Ansseau M., Dierick M., Buntinkx F., Cnockaert P., De Smedt J., Van Den Haute M., et al. High prevalence of mental disorders in primary care. J Affect Disord 78 (2004) 49-55
36. The ESEMeD/MHEDEA 2000 investigators. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 109 Suppl 420 (2004) 21-27
37. Van Vliet I.M., and De Beurs E. The MINI-International Neuropsychiatric Interview. A brief structured diagnostic psychiatric interview for DSM-IV en ICD-10 psychiatric disorders. Tijdschr Psychiatr 49 (2007) 393-397
38. Olfson M., and Gameroff M.J. Generalized anxiety disorder, somatic pain and health care costs. Gen Hosp Psychiatry 29 (2007) 310-316
39. Olssøn I., Mykletun A., and Dahl A.A. Recognition and treatment recommendations for generalized anxiety disorder and major depressive episode: A cross-sectional study among general practitioners in Norway. J Clin Psychiatry 8 (2006) 340-347
40. Baldwin D.S., Anderson I.M., Nutt D.J., Bandelow B., Bond A., Davidson J.R., et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 19 (2005) 567-596